ライフサイエンスコーパス: Stenotrophomonas

1 sis was more likely to detect Achromobacter, Stenotrophomonas, and Burkholderia, it was less likely t

2 Achromobacter, Stenotrophomonas, and Delftia were predominant bacteria

3 Achromobacter, Stenotrophomonas, and Delftia were prevalent in all dise

4 re positive for Burkholderia, Achromobacter, Stenotrophomonas, and Ralstonia clustered within the eNF

5 n microscopy revealed that Achromobacter and Stenotrophomonas formed a biofilm on the surface of cont

6 losoxidans (33%), and finally, pan-resistant Stenotrophomonas maltophilia (20%).

7 scens (5.5%), Enterobacter aerogenes (4.4%), Stenotrophomonas maltophilia (4.3%), Proteus mirabilis (

8 mobacter xylosoxidans (100%) followed by MDR Stenotrophomonas maltophilia (46%), MDR Achromobacter xy

9 ese were found to be P. aeruginosa (n = 10), Stenotrophomonas maltophilia (n = 1), and Burkholderia c

10 nt Stenotrophomonas maltophilia (n = 5), MDR Stenotrophomonas maltophilia (n = 26), and CF patients w

11 s mirabilis (n = 3), Serratia spp. (n = 10), Stenotrophomonas maltophilia (n = 43), Sphingobacterium

12 obacter xylosoxidans (n = 15), pan-resistant Stenotrophomonas maltophilia (n = 5), MDR Stenotrophomon

13 We sequence 552 genomes of the pathogen Stenotrophomonas maltophilia across 23 sites of the lung

14 s uncommon, occurring in 2 patients with MDR Stenotrophomonas maltophilia and 2 patients with MDR Ach

15 Stenotrophomonas maltophilia and Achromobacter (Alcalige

16 (LUV) and to kill the Gram negative bacteria Stenotrophomonas maltophilia and Escherichia coli.

17 coccus spp., and the opportunistic pathogens Stenotrophomonas maltophilia and Ochrobactrum anthropi w

18 reviewed for Achromobacter xylosoxidans and Stenotrophomonas maltophilia and their antibiotic suscep

19 Standard microbiology references describe Stenotrophomonas maltophilia as oxidase negative and var

20 significantly, an extensively drug-resistant Stenotrophomonas maltophilia clinical isolate expressing

21 ta-lactamase from the opportunistic pathogen Stenotrophomonas maltophilia has been determined at 1.7

22 Stenotrophomonas maltophilia has recently emerged as an

23 patients with Achromobacter xylosoxidans and Stenotrophomonas maltophilia have similar posttransplant

24 Metallo-beta-lactamase L1 from Stenotrophomonas maltophilia is a dinuclear Zn(II) enzym

25 Stenotrophomonas maltophilia is a Gram-negative bacteriu

26 Stenotrophomonas maltophilia is a gram-negative bacteriu

27 Stenotrophomonas maltophilia is a multiple-antibiotic-re

28 Stenotrophomonas maltophilia is a ubiquitous bacterium a

29 Stenotrophomonas maltophilia is an emerging opportunisti

30 Stenotrophomonas maltophilia is an emerging, opportunist

31 The Gram-negative bacterium Stenotrophomonas maltophilia is increasingly identified

32 The L1 metallo-beta-lactamase from Stenotrophomonas maltophilia is unique among this class

33 seobacterium meningosepticum isolates, and 1 Stenotrophomonas maltophilia isolate) producing IMP-1, I

34 26 Acinetobacter baumannii isolates, and 11 Stenotrophomonas maltophilia isolates.

35 , Escherichia coli, Serratia marcescens, and Stenotrophomonas maltophilia isolates.

36 rized a polysaccharide lyase (Smlt1473) from Stenotrophomonas maltophilia k279a, which exhibited sign

37 c mechanism of beta-lactam hydrolysis by the Stenotrophomonas maltophilia L1 metallo-beta-lactamase.

38 patients without Achromobacter xylosoxidans, Stenotrophomonas maltophilia or Bulkholderia cenocepacia

39 smid pB10 was shown to be highly unstable in Stenotrophomonas maltophilia P21 and Pseudomonas putida

40 To achieve the objective, Stenotrophomonas maltophilia strain ZL1 was used as a mo

41 rains, 5 Alcaligenes xylosoxidans strains, 5 Stenotrophomonas maltophilia strains, and 5 Pseudomonas

42 trains, 10 Pseudomonas aeruginosa strains, 8 Stenotrophomonas maltophilia strains, and 9 isolates bel

43 3 of [corrected] 35 home-use nebulizers, and Stenotrophomonas maltophilia was isolated from 4 of 35 h

44 Stenotrophomonas maltophilia was isolated from the respi

45 trocefin with metallo-beta-lactamase L1 from Stenotrophomonas maltophilia was studied using rapid-sca

46 Stenotrophomonas maltophilia WR-C is capable of forming

47 ratia marcescens, Staphylococcus aureus, and Stenotrophomonas maltophilia).

48 ureus [3 methicillin-resistant S. aureus], 2 Stenotrophomonas maltophilia, 1 Klebsiella pneumoniae) a

49 Staphylococcal aureus, Burkholderia cepacia, Stenotrophomonas maltophilia, Achromobacter xylosoxidans

50 ction of tobramycin-resistant P. aeruginosa, Stenotrophomonas maltophilia, and Achromobacter xylosoxi

51 s, Aeromonas caviae, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Enterococcus sp.

52 Klebsiella pneumoniae, Enterobacter cloacae, Stenotrophomonas maltophilia, and the Burkholderia cepac

53 pan-resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia, is poorly characterized.

54 increase isolation of Burkholderia cepacia, Stenotrophomonas maltophilia, or Alcaligenes xylosoxidan

55 With the exception of Stenotrophomonas maltophilia, these organisms are infreq

56 chromosomal carbapenemases are restricted to Stenotrophomonas maltophilia, to a few Bacteroides fragi

57 ionella pneumophila, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Vibrio cholerae, and Yersi

58 acter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia--all major threats to our c

59 structure of PabB from the emerging pathogen Stenotrophomonas maltophilia.

60 n Xylella fastidiosa and the human pathogen, Stenotrophomonas maltophilia.

61 he extensively drug resistant human pathogen Stenotrophomonas maltophilia.

62 talyzed by the dizinc L1 beta-lactamase from Stenotrophomonas maltophilia.

63 ermentative gram-negative bacilli, including Stenotrophomonas maltophilia.

64 nterocolitica O9, Escherichia hermannii, and Stenotrophomonas maltophilia.

65 ater samples with the denitrifying bacterium Stenotrophomonas nitritireducens, which selectively redu

66 microbial symbionts belonging to the genera Stenotrophomonas, Pseudomonas, and Enterobacter are resp

67 ere potential human pathogens Aeromonas sp., Stenotrophomonas sp. and an unculturable bacterium.

68 seudomonas spp. (non P. aeruginosa) (9), and Stenotrophomonas spp. (7).

69 in all disease groups, and Achromobacter and Stenotrophomonas were present in one asymptomatic contro